Literature DB >> 29026868

Antifungal Susceptibility Testing Practices at Acute Care Hospitals Enrolled in the National Healthcare Safety Network, United States, 2011-2015.

Snigdha Vallabhaneni1, Mathew Sapiano2, Lindsey M Weiner2, Shawn R Lockhart1, Shelley Magill2.   

Abstract

We assessed availability of antifungal susceptibility testing (AFST) at nearly 4000 acute care hospitals enrolled in the National Healthcare Safety Network. In 2015, 95% offered any AFST, 28% offered AFST at their own laboratory or at an affiliated medical center, and 33% offered reflexive AFST. Availability of AFST improved from 2011 to 2015, but substantial gaps exist in the availability of AFST.

Keywords:  antifungal agents; antifungal susceptibility testing; candidemia; laboratory practices; resistance

Year:  2017        PMID： 29026868      PMCID： PMC5632525          DOI： 10.1093/ofid/ofx175

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   3.835


  10 in total

1.  Antifungal susceptibility testing in teaching hospitals.

Authors:  Manjunath P Pai; Susan L Pendland
Journal:  Ann Pharmacother       Date:  2003-02       Impact factor: 3.154

2.  Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.

Authors:  D N Shah; R Yau; J Weston; T M Lasco; M Salazar; H R Palmer; K W Garey
Journal:  J Antimicrob Chemother       Date:  2011-06-23       Impact factor: 5.790

3.  Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.

Authors:  Angela Ahlquist Cleveland; Monica M Farley; Lee H Harrison; Betsy Stein; Rosemary Hollick; Shawn R Lockhart; Shelley S Magill; Gordana Derado; Benjamin J Park; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2012-08-14       Impact factor: 9.079

4.  Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016.

Authors:  Snigdha Vallabhaneni; Alex Kallen; Sharon Tsay; Nancy Chow; Rory Welsh; Janna Kerins; Sarah K Kemble; Massimo Pacilli; Stephanie R Black; Emily Landon; Jessica Ridgway; Tara N Palmore; Adrian Zelzany; Eleanor H Adams; Monica Quinn; Sudha Chaturvedi; Jane Greenko; Rafael Fernandez; Karen Southwick; E Yoko Furuya; David P Calfee; Camille Hamula; Gopi Patel; Patricia Barrett; Patricia Lafaro; Elizabeth L Berkow; Heather Moulton-Meissner; Judith Noble-Wang; Ryan P Fagan; Brendan R Jackson; Shawn R Lockhart; Anastasia P Litvintseva; Tom M Chiller
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-11       Impact factor: 17.586

5.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

6.  First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.

Authors:  Nathan P Wiederhold; Veronica Garcia Gil; Felipe Gutierrez; Jonathan R Lindner; Mohammad T Albataineh; Dora I McCarthy; Carmita Sanders; Hongxin Fan; Annette W Fothergill; Deanna A Sutton
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

7.  Multistate point-prevalence survey of health care-associated infections.

Authors:  Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

8.  Declining incidence of candidemia and the shifting epidemiology of Candida resistance in two US metropolitan areas, 2008-2013: results from population-based surveillance.

Authors:  Angela Ahlquist Cleveland; Lee H Harrison; Monica M Farley; Rosemary Hollick; Betsy Stein; Tom M Chiller; Shawn R Lockhart; Benjamin J Park
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

9.  Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017.

Authors:  Sharon Tsay; Rory M Welsh; Eleanor H Adams; Nancy A Chow; Lalitha Gade; Elizabeth L Berkow; Eugenie Poirot; Emily Lutterloh; Monica Quinn; Sudha Chaturvedi; Janna Kerins; Stephanie R Black; Sarah K Kemble; Patricia M Barrett; Kerri Barton; D J Shannon; Kristy Bradley; Shawn R Lockhart; Anastasia P Litvintseva; Heather Moulton-Meissner; Alicia Shugart; Alex Kallen; Snigdha Vallabhaneni; Tom M Chiller; Brendan R Jackson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-05-19       Impact factor: 17.586

10.  Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008-2014.

Authors:  Snigdha Vallabhaneni; Angela A Cleveland; Monica M Farley; Lee H Harrison; William Schaffner; Zintar G Beldavs; Gordana Derado; Cau D Pham; Shawn R Lockhart; Rachel M Smith
Journal:  Open Forum Infect Dis       Date:  2015-12-14       Impact factor: 3.835
  10 in total
  4 in total

1.  Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.

Authors:  Chris Edens; Kathryn A Haass; Melissa Cumming; Anthony Osinski; Lynne O'Hearn; Kelly Passanisi; Lynn Eaton; Paul Visintainer; Alexandra Savinkina; Matthew J Kuehnert; Sridhar V Basavaraju; Chester Andrzejewski
Journal:  Transfusion       Date:  2018-11-14       Impact factor: 3.157

2.  Survival in Patients with Candida glabrata Bloodstream Infection Is Associated with Fluconazole Dose.

Authors:  Gregory A Eschenauer; Peggy L Carver; Twisha S Patel; Shu-Wen Lin; Kenneth P Klinker; Manjunath P Pai; Simon W Lam
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

3.  Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016.

Authors:  Mitsuru Toda; Sabrina R Williams; Elizabeth L Berkow; Monica M Farley; Lee H Harrison; Lindsay Bonner; Kaytlynn M Marceaux; Rosemary Hollick; Alexia Y Zhang; William Schaffner; Shawn R Lockhart; Brendan R Jackson; Snigdha Vallabhaneni
Journal:  MMWR Surveill Summ       Date:  2019-09-27

4.  Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor.

Authors:  Lucia Simonicova; W Scott Moye-Rowley
Journal:  PLoS Genet       Date:  2020-08-25       Impact factor: 5.917
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.